T oxic shock syndrome remains a serious disease characterized by rapid onset of fever, rash, shock, and multiorgan involvement (1) (2) (3) (4) (5) . Although the majority of cases are associated with menstruation and tampon use, similar manifestations have been increasingly recognized in other settings associated with focal Staphylococcus aureus infections (1) (2) (3) (4) (5) (6) . Exoproteins purified from S. aureus, particularly toxic shock syndrome toxin-1(TSST1), have been implicated in the pathogenesis (7, 8) , but the mechanism by which TSST1 results in disease remains unclear.
Previous studies have demonstrated that S. aureus enterotoxins, including TSST1, are powerful stimulators of T cell proliferation in culture, in the presence of APCs bearing class II major histocompatibility antigens (reviewed in reference 9). Recent work from our laboratories showed that stimulation of human T cells by individual bacterial toxins is selective for cells expressing particular TCR 0 chain variable (VO) gene segments (10, 11) . Other variable elements (DO, J/3, Vcx, Jot) of the TCR contribute little to the recognition of these Vo-specific superantigens, as they do for conventional antigens (9) (10) (11) . Studies using a modified PCR to quantitate V/3 expression in a population of T cell blasts demonstrated that the majority of T cells stimulated by TSST1 in culture specifically expressed Vf2. Based on these in vitro findings, the present studies were initiated in patients with toxic shock syndrome.
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Materials and Methods
Patients. Eight patients were referred for study by their private physicians or through the Colorado Department of Public Health (Pam Shillam, Epidemiology group), and all met the definition for severe toxic shock syndrome (3, 4) . Major criteria (all required) for the diagnosis include fever (38.8°C), rash (diffuse erythematous rash evolving to desquamation), and hypotension (systolic blood pressure <90 mmHg for adults and/or orthostatic syncope or dizziness) . Minor criteria (three required) for the definition include diarrhea and/or vomiting, muscular involvement, mucous membrane hyperemia, decreased renal function or pyuria, elevated liver enzymes, platelet count <100,000/mm 3, and disorientation or altered state of consciousness . Disease in all patients appeared to be related to a focus of S. aureus infection .
Stimulation and Analysis ofPeripheral Blood T Cells. PBMC were isolated from heparinized blood, and to increase the production offunctional TCR mRNA, T cells were stimulated with anti-CD3 antibody and IIr2 (10, 11) . The cells were then used for either immunofluorescence staining or quickly frozen in liquid nitrogen for subsequent RNA extraction. Indirect immunofluorescence was performed as described using mAbs directed to CD4, CD8, and to epitopes on TCRs bearing V05, Va6, V08, and V/312 (10) .
PCR and Quantitation of Amplified Products. Total RNA prepared from stimulated cells was used for the synthesis offirst strand cDNA as described (10, 11) . For each PCR, oligonucleotide primers included a V/ispecific oligomer and an oligomer from the downstream (3 chain constant region (CO primer) as one pair, and two oligomers from the Cu region as the other pair. The sequences of the specific primers used and details of the PCR have been published (11) . Amplification was performed with -25 cycles, chosen to ensure that the amount of product synthesized was proportional to the amount of V(3 mRNA in the original preparation . For quantitation of amplified products, 12P end-labeled 3' primers (-5 x 105 cpm each) were added to the reactions. The amplified products were separated on 2% agarose gels, dried, and analyzed with an Ambis Radioanalytic Imaging System (Ambis Systems, San Diego, CA).
Results and Discussion
T cells from patients and control individuals were stimulated in culture with anti-CD3 antibody and 11,2 . Using cDNA generated from T cell blast RNA and a quantitative PCR, TCR gene segments encoding V02, V05 (5 .2 and 5.3), Controls (n = 7) (mean ± SE) 0 .09 ± 0.01
Peripheral blood was drawn from patients 3-14 d after the onset of symptoms . t Quantitation of the amount of labeled primer incorporated into the V(3 and Ca bands (see Fig. 1 ) allowed for calculation of the ratios presented (11) . S Primers specific for a sequence common to V/35 .2 and 5.3 or V08.1 and 8.2 were used (11) .
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T Cells in Toxic Shock Syndrome V08 (8 .1 and 8.2), and V012 were amplified and quantitated .
To control for the amount of TCR cDNA in the reaction mixture, a Ca gene segment was also amplified in each reaction . Fig. 1 shows results with T cells from one patient and a concomitantly studied normal individual. A striking increase in amplified V02 DNA is apparent in the patient compared with control, whereas little difference is observed in Ca or other Va products . The data in Table 1 There is currently no mAb specific for human T cells expressing V)32, and therefore no direct method to quantitate the percentage of these cells in peripheral blood. However, based on those VOs against which specific mAbs are available, V#/Cot values obtained with the PCR can be converted to the percentage of T cells expressing the respective Vii (11) . PCR data in this study suggest that Va2+ T cells in normal individuals are -10% of the peripheral blood T cell population. In contrast, peak values for patients 1 and 2 were -70% and 30%, respectively, emphasizing the striking stimulation occurring in some patients .
Serial samples were obtained from two patients to examine longitudinal changes in T cell subsets after the acute disease.
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Brief Definitive Report Fig. 2 shows that V02+ T cell percentages in these patients returned nearly to normal by 45-60 d after the acute episode. The fact that levels do normalize indicates that the increase in V,Q2+ T cells occurs after the onset of toxic shock syndrome and is not a factor influencing susceptibility. These serial studies also emphasize the relative lack of fluctuation over time in T cell subsets expressing other Vf segments, an observation also made in studies of normal individuals (10) . Three of the eight patients studied did not demonstrate elevated V02 levels. Our initial hypothesis was that disease in these patients was caused by a S. aureus toxin different than TSST1, and that other sets of T cells would be expanded in a V(3specific fashion. We therefore measured a much larger proportion of the T cell repertoire in these patients and controls using 22 different oligonucleotide Vii-specific primers (11) and quantitative PCR. Despite accounting for nearly 70% of the T cell repertoire, selective expansion of another T cell subset could not be demonstrated (data not shown) . It is still possible that an expanded subset was not included in this analysis . However, we believe it is more likely that selective Vila expansion was not reflected in the peripheral blood of some patients because of the timing of blood sampling. Studies in rodents after immunization have indicated that antigenspecific T cells are sequestered in lymphoid tissues (the site of antigen activation) where they are activated and expanded in numbers before emigrating into the recirculating pool (12, 13) . It is interesting that two of the three patients with normal V02+ T cell levels were studied within 3 d of the onset of symptoms, whereas the highest Va2+ T cell percentages were observed -10-14 d after onset of disease.
It is not entirely clear as to how a toxin such as TSST 1 interacts with the host to produce the diverse manifestations of toxic shock syndrome. There is little evidence that TSST1 directly mediates the decreased vasomotor tone and increased capillary leakage that results in shock, and humoral mediators such as ILA and especially TNF have been implicated (14, 15) . These cytokines can be shown to be released in cultures of mononuclear cells or macrophages after the addition of TSST1 or other S. aureus enterotoxins (reviewed in references 9 and 14) . Recent studies in mice have also indicated that the toxicity of S. aureus enterotoxin B is dependent on the presence of T cells (16) . In support of a critical role for T cells in the human disease, the data presented here indicate that during toxic shock syndrome T cell stimulation occurs on a scale not observed in response to conventional antigens (9-11) . These activated T cells are likely to be releasing large quantities of lymphokines such as IL-2, IFN-,y and lymphotoxin (TNF-(3), all of which could be involved in the induction of shock (15, 17, 18) .
